Ligand Pharmaceuticals News

8-K: Current report

Apr 19 16:11 ET

Ligand Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 1 16:12 ET

Ligand Pharmaceuticals | 8-K: Ligand Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 27 07:25 ET

Ligand Pharmaceuticals | 8-K: Current report

Jan 8 00:00 ET

Ligand Pharmaceuticals | 8-K: Current report

Dec 1, 2023 08:25 ET

Ligand Pharmaceuticals | 8-K/A: Ligand Reports Third Quarter 2023 Financial Results

Nov 9, 2023 21:48 ET

Ligand Pharmaceuticals | 8-K: Ligand Reports Third Quarter 2023 Financial Results

Nov 8, 2023 16:08 ET

Ligand Pharmaceuticals | 8-K: Current report

Oct 18, 2023 09:03 ET

Ligand Pharmaceuticals | 8-K: Current report

Oct 17, 2023 19:24 ET

Ligand Pharmaceuticals | 8-K: Current report

Sep 27, 2023 08:38 ET

Ligand Pharmaceuticals | 8-K: Current report

Sep 18, 2023 17:26 ET

Ligand Pharmaceuticals | 8-K: Ligand Reports Second Quarter 2023 Financial Results

Aug 8, 2023 16:02 ET

Ligand Pharmaceuticals | 8-K: Current report

Jun 9, 2023 17:00 ET

Ligand Pharmaceuticals | 8-K: Ligand Reports First Quarter 2023 Financial Results

May 4, 2023 16:06 ET

Ligand Pharmaceuticals | DEFA14A: Others

Apr 20, 2023 16:07 ET

Ligand Pharmaceuticals | DEF 14A: Definitive proxy statements

Apr 20, 2023 16:05 ET

Ligand Pharmaceuticals | 8-K: Current report

Mar 13, 2023 08:02 ET

Ligand Pharmaceuticals | 8-K: Ligand Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 22, 2023 16:05 ET

Ligand Pharmaceuticals | 8-K: Current report

Dec 14, 2022 16:07 ET

Ligand Pharmaceuticals | 8-K: Current report

Dec 5, 2022 07:03 ET